Ablation Arrhythmia Congenital Heart Disease 
Heart BMJ
FEBRUARY 12, 2025
Background Atrial arrhythmias (AA) and heart failure (HF) are major causes of hospitalisation in adult congenital heart disease (ACHD). Methods In this single-centre retrospective cohort study, data from 3995 patients with ACHD were analysed.
HeartRhythm
MARCH 31, 2025
Adults with congenital heart disease (ACHD) are at increased risk for ventricular arrhythmias due to structural abnormalities. Catheter ablation (CA) is a key therapeutic option, but its complications in this population remain underexplored.
HeartRhythm
MARCH 31, 2025
Enhanced survival rates among adults with congenital heart disease (ACHD) has led to a higher prevalence of arrhythmias in this population, the most common being atrial fibrillation/flutter. However, the safety of catheter ablation (CA) for these arrhythmias in ACHD remains understudied.
HeartRhythm
MARCH 31, 2025
Patients with congenital heart disease (CHD) are at high risk for supraventricular tachyarrhythmias including atrial fibrillation (AF) and atrial tachycardia (AT).
HeartRhythm
APRIL 30, 2024
Patients with adult congenital heart disease (ACHD) such as Tetralogy of Fallot (ToF) are at high risk for ventricular arrhythmias requiring ablation. Less common syndromes such as double outlet right ventricle (DORV) and Williams Syndrome provide additional complications.
Journal of Cardiovascular Electrophysiology
JANUARY 24, 2025
ABSTRACT Introduction Data regarding safety and long-term outcome of very high-power-short duration (vHPSD) ablation in adult congenital heart disease (ACHD) patients with paroxysmal or persistent atrial fibrillation (AF) are lacking. Regardless of CHD complexity, no vHPSD ablation modality related complications occurred.
HeartRhythm
SEPTEMBER 5, 2024
Post-operative arrhythmias are most often transient and medically treated, but some patients may require electrophysiology study (EPS) and ablation.
Expert insights. Personalized for you.
59 
Let's personalize your content